Buy Adequan Multi-dose Online

We are pleased to introduce “Adequan Multi-dose,” an advanced joint support solution designed to promote joint health and mobility in animals. With worldwide discreet delivery, we ensure that your beloved companions receive the care they need, no matter where you are.

Key Features and Benefits:

1. Comprehensive Joint Support:
   Adequan Multi-dose is specifically formulated to provide comprehensive support to the joints in animals. It contains a potent blend of ingredients that work synergistically to promote joint health, enhance lubrication, and support the overall structure and function of joints.
2. Promotes Cartilage Health:
   Cartilage is essential for joint mobility and acts as a cushion between bones. Adequan Multi-dose helps promote cartilage health by providing necessary nutrients and building blocks for cartilage repair and maintenance. By supporting cartilage health, Adequan Multi-dose helps maintain joint integrity and mobility.
3. Reduces Joint Inflammation:
   Inflammation is a common factor in joint discomfort and stiffness. Adequan Multi-dose has anti-inflammatory properties that help reduce joint inflammation, providing relief and promoting greater comfort in animals. By addressing inflammation, Adequan Multi-dose supports overall joint health and mobility.
4. Enhances Joint Lubrication:
   Adequate joint lubrication is vital for smooth and pain-free movement. Adequan Multi-dose helps enhance joint lubrication, ensuring that joints move freely and without friction. Improved joint lubrication contributes to enhanced mobility, flexibility, and overall joint function in animals.
5. Convenient Multi-dose Format:
   Adequan Multi-dose is available in a convenient multi-dose format, allowing for easy administration and precise dosage control. The multi-dose vial ensures that you have an adequate supply of Adequan on hand to support your animal’s joint health needs.
6. Safe and Discreet Worldwide Delivery:
   Equicurepharm understands the importance of convenience and privacy when it comes to ordering animal healthcare products. We offer discreet worldwide delivery of Adequan Multi-dose, ensuring that your order arrives safely and securely at your doorstep.

Usage Instructions:

Adequan Multi-dose should be administered under the guidance of a veterinarian. The dosage and frequency of administration will depend on the specific needs of your animal, the severity of joint issues, and other factors. It is crucial to follow the veterinarian’s instructions carefully and consult them for any questions or concerns.

Note: Adequan Multi-dose should only be used under the supervision of a veterinarian. They will be able to provide a comprehensive evaluation of your animal’s joint health, diagnose any existing conditions, and determine the appropriate treatment plan.

Trust Equicurepharm for Exceptional Animal Healthcare Solutions:

Equicurepharm is committed to providing superior products that prioritize the health and well-being of animals. With Adequan Multi-dose, you can provide advanced joint support to your beloved companions, promoting their joint health, mobility, and overall quality of life.

Experience the difference with Adequan Multi-dose – order now and give your animals the joint support they deserve, delivered discreetly to your doorstep worldwide. Trust Equicurepharm for reliable and effective animal healthcare solutions.

Adequan Multi-dose Brand of Polysulfated Glycosaminoglycan (PSGAG)
Solution 100 mg/mL in a 50 mL Preserved Multi-Dose Vial
For Intramuscular Use In Horses Only. Not for Intra-Articular Use.

CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian.

DESCRIPTION:
Each mL contains Polysulfated Glycosaminoglycan 100 mg, Benzyl Alcohol 0.9% v/v as a preservative, and Water for Injection q.s. Sodium Hydroxide and/or Hydrochloric Acid added when necessary to adjust pH. The solution is clear, colorless to slightly yellow.

PHARMACOLOGY:
Polysulfated Glycosaminoglycan is chemically similar to the glycosaminoglycans in articular cartilage matrix. PSGAG is a potent proteolytic enzyme inhibitor and diminishes or reverses the pathologic processes of traumatic or degenerative joint disease which result in a net loss of cartilage matrix components. PSGAG improves joint function by reducing synovial fluid protein levels and increasing synovial fluid hyaluronic acid concentration in traumatized equine carpal and hock joints.

Adequan Multi-dose INDICATIONS:
Adequan® i.m. Multi-Dose is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

DOSAGE AND ADMINISTRATION:
Practice aseptic techniques in withdrawing each dose to decrease the possibility of post-injection bacterial infections. Adequately clean and disinfect the stopper prior to entry with a sterile needle and syringe. Use only sterile needles, and use each needle only once.

The vial stopper may be punctured a maximum of 10 times.

The recommended dose of Adequan® i.m. Multi-Dose in horses is 500 mg every 4 days for 28 days intramuscularly. The injection site must be thoroughly cleansed prior to injection. Do not mix Adequan® i.m. Multi-Dose with other drugs or solvents.

CONTRAINDICATIONS:
There are no known contraindications to the use of intramuscular Polysulfated Glycosaminoglycan.

WARNINGS:
Do not use in horses intended for human consumption. Not for use in humans. Keep this and all medications out of the reach of children.

PRECAUTIONS:
The safe use of Adequan® i.m. Multi-Dose in horses used for breeding purposes, during pregnancy, or in lactating mares has not been evaluated.

SAFETY AND EFFICACY:
Safety and efficacy studies utilizing Adequan® i.m. Multi-Dose were not performed. Adequan® i.m. Multi-Dose was approved based on the conclusion that the safety and effectiveness of Adequan® i.m. Multi-Dose will not differ from that demonstrated for the original formulation of Adequan® i.m.

ANIMAL SAFETY:
Animal Safety studies utilizing Adequan® i.m. Multi-Dose were not performed. Safety studies were conducted in horses using the single dose formulation. Doses as high as 2,500 mg were administered intramuscularly to 6 horses twice a week for 12 weeks. This dosage is 5 times the recommended dosage and 3 times the recommended therapeutic regimen. Clinical observations revealed no soreness or swelling at the injection site or in the affected joint. No animal had any clinical or laboratory evidence of toxicity.

STORAGE CONDITIONS:
Store at 20°-25°C (68°-77°F); excursions permitted to 15°-30°C (59°-86°F) (See USP Controlled Room Temperature). Avoid prolonged exposure to temperatures ≥ 40°C (104°F).

Use within 28 days of first puncture and puncture a maximum of 10 times. Dispose of spent needles in accordance with all federal, state and local environmental laws.

HOW SUPPLIED:

Adequan® i.m. Multi-Dose solution, 5,0000 mg/50 mL (100 mg/mL) in 50 mL multi-dose glass vials.